245 related articles for article (PubMed ID: 37374142)
1. The Intricate Interplay between Cancer Stem Cells and Oncogenic miRNAs in Breast Cancer Progression and Metastasis.
Tsintarakis A; Papalouka C; Kontarini C; Zoumpourlis P; Karakostis K; Adamaki M; Zoumpourlis V
Life (Basel); 2023 Jun; 13(6):. PubMed ID: 37374142
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs, a subpopulation of regulators, are involved in breast cancer progression through regulating breast cancer stem cells.
Fan X; Chen W; Fu Z; Zeng L; Yin Y; Yuan H
Oncol Lett; 2017 Nov; 14(5):5069-5076. PubMed ID: 29142594
[TBL] [Abstract][Full Text] [Related]
3. The role of microRNAs in breast cancer stem cells.
Schwarzenbacher D; Balic M; Pichler M
Int J Mol Sci; 2013 Jul; 14(7):14712-23. PubMed ID: 23860207
[TBL] [Abstract][Full Text] [Related]
4. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
[TBL] [Abstract][Full Text] [Related]
5. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs in breast cancer stem cells.
Huang Y; Mo W; Ding X; Ding Y
Med Oncol; 2023 May; 40(6):177. PubMed ID: 37178429
[TBL] [Abstract][Full Text] [Related]
8. Fate decisions of breast cancer stem cells in cancer progression.
Xu H; Zhang F; Gao X; Zhou Q; Zhu L
Front Oncol; 2022; 12():968306. PubMed ID: 36046046
[TBL] [Abstract][Full Text] [Related]
9. The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147
Lv Y; Wang T; Fan J; Zhang Z; Zhang J; Xu C; Li Y; Zhao G; He C; Meng H; Yang H; Wang Z; Liu J; Chen J; Wang L
Tumour Biol; 2017 Apr; 39(4):1010428317695927. PubMed ID: 28381172
[TBL] [Abstract][Full Text] [Related]
10. Do Different Stemness Markers Identify Different Pools of Cancer Stem Cells in Malignancies: A Study on ER+ and ER-Breast Cancer Cell Lines.
Chopra S; Goel S; Thakur B; Bhatia A
Pathol Oncol Res; 2020 Jan; 26(1):371-378. PubMed ID: 30361903
[TBL] [Abstract][Full Text] [Related]
11. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
Sousa B; Ribeiro AS; Paredes J
Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
[TBL] [Abstract][Full Text] [Related]
13. Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity.
Zhang R; Tu J; Liu S
Semin Cancer Biol; 2022 Jul; 82():11-25. PubMed ID: 33737107
[TBL] [Abstract][Full Text] [Related]
14. Role of microRNAs in the regulation of breast cancer stem cells.
Liu S; Clouthier SG; Wicha MS
J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
[TBL] [Abstract][Full Text] [Related]
15. The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer.
He L; Wick N; Germans SK; Peng Y
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944829
[TBL] [Abstract][Full Text] [Related]
16. Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells.
Chen W; Zhang L; Liu S; Chen C
Cells; 2022 Sep; 11(19):. PubMed ID: 36230903
[TBL] [Abstract][Full Text] [Related]
17. Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome.
El Helou R; Wicinski J; Guille A; Adélaïde J; Finetti P; Bertucci F; Chaffanet M; Birnbaum D; Charafe-Jauffret E; Ginestier C
Stem Cells; 2014 Nov; 32(11):3031-6. PubMed ID: 25069843
[TBL] [Abstract][Full Text] [Related]
18. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
19. Key Epigenetic Events Involved in the Maintenance of Breast Cancer Stem Cells.
Pourmahdi M; Saber A; Rajabi A; Abdolahi S; Ebrahimi P; Safaralizadeh R
Curr Stem Cell Res Ther; 2021; 16(7):877-887. PubMed ID: 33563177
[TBL] [Abstract][Full Text] [Related]
20. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy.
Cui Y; Zhao M; Yang Y; Xu R; Tong L; Liang J; Zhang X; Sun Y; Fan Y
Acta Biomater; 2022 Oct; 152():380-392. PubMed ID: 36028199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
